Table 2. Factors associated with CSF PGRNa.
Factors | Mean±SD | P-value | |
Gender | Male (n = 93) | 1.67±0.61 | ns |
Female (n = 14) | 1.49±0.54 | ||
Race | Black (n = 34) | 1.50±0.76 | ns |
Other (n = 14) | 1.72±0.55 | ||
White (n = 59) | 1.72±0.50 | ||
AIDS | No (n = 39) | 1.76±0.71 | ns |
Yes (n = 68) | 1.59±0.52 | ||
ART Use | No (n = 23) | 1.77±0.81 | ns |
Yes (n = 84) | 1.62±0.53 | ||
Neurocognitive status | Impaired (n = 58) | 1.59±0.64 | ns |
Normal (n = 49) | 1.72±0.54 | ||
CSF HIV VL | Non-detectable (n = 79) | 1.54±0.56 | <0.001 |
Detectable (n = 28) | 1.97±0.59 | ||
Current CD4+ T-cell count | <200 (n = 22) | 1.64±0.61 | ns |
> = 200 (n = 84) | 1.65±0.60 |
CSF PGRN was square-root transformed,
ns: not significant.